Table 3.
Open in new tab

Estimates of the fixed effects parameters, using the generalized estimated equations, in the prediction of refractoriness to RAI treatment in Graves disease

Variable independentBSEOR (95% CI)P
Log10 TSH−0.920.380.40 (0.19-0.85).017a
fT3−0.020.040.98 (0.91-1.06).90
Elecsys TRAb0.060.051.06 (0.97-1.16).25
Immulite TSI−0.050.100.95 (0.78-1.16).62
Elecsys TRAb * Immulite TSI0.010.001.00 (0.99-1.01).70
Variable independentBSEOR (95% CI)P
Log10 TSH−0.920.380.40 (0.19-0.85).017a
fT3−0.020.040.98 (0.91-1.06).90
Elecsys TRAb0.060.051.06 (0.97-1.16).25
Immulite TSI−0.050.100.95 (0.78-1.16).62
Elecsys TRAb * Immulite TSI0.010.001.00 (0.99-1.01).70

Abbreviations: fT3, free triiodothyronine; RAI, radioactive iodine; TRAb, thyrotropin receptor autoantibody; TSH, thyrotropin; TSI, thyroid-stimulating immunoglobulin.

aP < .05.

Table 3.
Open in new tab

Estimates of the fixed effects parameters, using the generalized estimated equations, in the prediction of refractoriness to RAI treatment in Graves disease

Variable independentBSEOR (95% CI)P
Log10 TSH−0.920.380.40 (0.19-0.85).017a
fT3−0.020.040.98 (0.91-1.06).90
Elecsys TRAb0.060.051.06 (0.97-1.16).25
Immulite TSI−0.050.100.95 (0.78-1.16).62
Elecsys TRAb * Immulite TSI0.010.001.00 (0.99-1.01).70
Variable independentBSEOR (95% CI)P
Log10 TSH−0.920.380.40 (0.19-0.85).017a
fT3−0.020.040.98 (0.91-1.06).90
Elecsys TRAb0.060.051.06 (0.97-1.16).25
Immulite TSI−0.050.100.95 (0.78-1.16).62
Elecsys TRAb * Immulite TSI0.010.001.00 (0.99-1.01).70

Abbreviations: fT3, free triiodothyronine; RAI, radioactive iodine; TRAb, thyrotropin receptor autoantibody; TSH, thyrotropin; TSI, thyroid-stimulating immunoglobulin.

aP < .05.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close